维普期刊资源整合服务平台（V6.5）

91篇 您的检索式：作者名="Faergeman O"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Follow-up study of patients randomized in the Seandinavian simvaslalin survival study (4S) of cholesterol lowering 显示文摘	Pedersen TR Wilhelmsen L Faergeman O	2000	Am J Cardiol2000，86，：	1
2	High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction, the IDEAL study: a randomized controlled trial显示文摘	Pedersen T R Faergeman O Kastelein J J P etal	2005	JAMA2005，294，19：	1
3	High-dose atorvastatin vs usu- M-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial 显示文摘	Pedersen TR Faergeman O Kastelein ]J	2005	JAMA2005，284，：	1
4	High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial in- farction : the IDEAL study : a randomized controlled trial 显示文摘	Pedersen TR Faergeman O Kastelein JJ	2005	JAMA2005，294，19：	1
5	High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction:the IDEAL study:a randomized controlled trial显示文摘	Pedersen TR Faergeman O Kastelein JJ	2005	JAMA2005，294，：	1
6	High-dose atrovastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction:the IDEAL study:a randomized controlled显示文摘	Pedersen TR Faergeman O Kastelein JJ	2005	JAMA2005，294，：	1
7	High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial显示文摘	PEDERSEN T R FAERGEMAN O KASTELEIN J J	2005	JAMA2005，294，19：	1
8	Lipopro-tein changes and reduction in the incidence of major coro-nary heart disease events in the Scandinavian simvastatinsurvival study (4S)显示文摘	Pedersen TR Olsson AG Faergeman O	2004	Atheroscler Suppl2004，5，3：	1
9	High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction:the IDEAL study:a randomized controlled trial显示文摘	Pedersen TR Faergeman O Kastelein JJ	2005	JAMA2005，294，19：	1
10	HiSh-dose atorvaslatin vs usual-dose simvaslatin for secondary prevention after myocardial infarction:the IDEAL study:a randomized controlled trial显示文摘	Faergeman O Knstelein JJ	2005	JAMA2005，294，：	1
11	Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)显示文摘	Pedersen TR Olsson AG Faergeman O	1998	Circulation1998，97，15：	1
12	High- dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial显示文摘	Pedersen TR Faergeman O Kastelein J J	2005	J AMA2005，294，：	1
13	High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction:the IDEAL study:a randomized controlled trial显示文摘	Pedersen TR Faergeman O Kastelein JJ		0，，：	1
14	Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)显示文摘	Pedersen TR Olsson AG Faergeman O	1998	Circulation1998，97，：	1
15	Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild -to -moderate base-line elevations in alanine aminotransferase levels显示文摘	Tikkanen MJ Fayyad R Faergeman O	2013	Internation-al Journal of Cardiology2013，168，4：	1
16	Compari- son of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late ( five years) after acute myocardial infarction from the incre- mental decrease in end points through aggressive lipid lowering trial 显示文摘	Pedersen T R Cater N B Faergeman O	2010	Am J Cardiol2010，106，3：	1
17	Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)显示文摘	Pedersen TR Olsson AG Faergeman O	1998	Circulation1998，97，15：	1
18	Highdose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial 显示文摘	Pedersen TR Faergeman O Kastelein J J	2005	JAMA2005，294，19：	1
19	Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering显示文摘	Pedersen TR Wilhelmsen L Faergeman O	2000	Am J Cardiol2000，86，3：	1
20	Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)显示文摘	Pedersen TR Olsson AG Faergeman O	2004	Atheroscler Suppl2004，5，3：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示